Search Results 1941-1950 of 17051 for monoclonal antibody

1. YA-101 in Subjects with Multiple System Atrophy - Mayo Clinic

   ... antibody, and hepatitis C virus (HCV). Subjects taking strong inhibitors and inducers of CYP2C8, and strong inhibitors of the P-gp transporter after ...

2. Bone marrow biopsy and aspiration - Doctors & Departments - Mayo Clinic

   Monoclonal gammopathy of undetermined significance (MGUS) · Myelodysplastic syndromes · Myelofibrosis · Neuroblastoma · Non-Hodgkin lymphoma · Polycythemia vera ...

3. Oatd-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis - Mayo Clinic

   Known positivity for Human Immunodeficiency Virus (HIV 1/2 antibodies), hepatitis B virus (HBV), or hepatitis C virus (HCV), or detected at screening; Severe ...

4. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

   Any type of anticancer antibody or cytotoxic chemotherapy within 4 weeks;; Radiation therapy for bone metastasis within 2 weeks, any other external radiation ...

5. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g. ...

6. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   < 4 weeks for immunotherapy or antibody therapy. Participants must have recovered (≤ Grade 2 or at pretreatment baseline) from AEs from previously ...

7. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

   ... antibodies to total anti-HBc with or without the presence of anti-HBs) must be screened using RT-PCR measurement of HBV DNA levels. Those who are RT PCR ...

8. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   0 Grade 4 immune-related AE due to adjuvant CTLA-4 or PD-1 blocking antibody. Not fully recovered from adverse events (to Grade 1 or less [per CTCAE v5.0] ...

9. A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis - Mayo Clinic

   antibody - Study participant must have ≥ 2 seizures/week during the Screening Period or have experienced such seizures that stopped following high dose ...

10. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

    Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA ...